ORLive.com, BroadcastMed’s premiere surgical broadcasting website, is proud to present a live webinar on the ConforMIS iTotal® G2 Patient-Specific Knee Replacement System on November 8 at 7:00pm EST.

ConforMIS expanded its Series E financing to $167.7 million, according to a News-Medical report. Participants include government investment funds, private equity funds and sovereign wealth funds in ...

ConforMIS said today that the first surgeries involving the iTotal CR knee resurfacing system were successfully completed in hospitals around the U.S. And, according to a company release, the ...

BILLERICA, Mass., Jan. 04, 2018 (GLOBE NEWSWIRE) -- ConforMIS, Inc. (NASDAQ:CFMS), a medical technology company that offers joint replacement implants designed and manufactured to fit each patient’s ...

The iTotal® PS total knee replacement system is designed so that its patient-specific implants fit the unique size and shape of each patient’s knee, and provide optimal stability throughout the full ...

BEDFORD, Mass.--(BUSINESS WIRE)--ConforMIS, Inc., a privately held medical device company pioneering patient-specific orthopedic implants, announced today it has appointed 30-year business and ...

BILLERICA, Mass., June 22, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) today announced 510(k) clearance by the U.S. Food and Drug Administration of the Company’s next generation iTotal® ...

CHARLOTTE, N.C.--(BUSINESS WIRE)--Camstar Systems, Inc. announced today that ConforMIS, the leading provider of patient-specific implants and instrumentation, has deployed Camstar’s Manufacturing ...

Personalized 3-D printed joint implants may seem like a no-brainer. But troubled small-cap ConforMIS ($CFMS) has struggled to dig in its heels since a $135 million ...